XDH
protein-codingxanthine dehydrogenase
Gene summary
Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification. Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism. [provided by RefSeq, Jan 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~80.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010209
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010209
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010209
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0010209
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Musculoskeletal; Renal
Intervention: Biochemical; Renal
Rationale: Dietary measures (eg, purine restricted, increased fluid intake) and medical measures (eg, allopurinol) can be effective
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to XDH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000379.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 21 | 143 | 3 | 167 | ||
| missense | 2 | 438 | 41 | 3 | 484 | |
| nonsense | 5 | 11 | 16 | |||
| start loss | 0 | |||||
| frameshift | 11 | 9 | 2 | 22 | ||
| splice donor/acceptor (+/-2bp) | 1 | 19 | 4 | 24 | ||
| Total | 17 | 41 | 465 | 184 | 6 | 713 |
Highest pathogenic variant AF is 0.00092517544
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000370.2 | 36 | MANE Select | |
| Ensembl | ENSP00000368727.3 | 36 | MANE Select | |
| Ensembl | ENSP00000549579.1 | 36 | Standard | |
| Ensembl | ENSP00000549579.1 | 36 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Doxorubicin Pathway (Cancer Cell), Pharmacodynamics
- Peroxisome - Homo sapiens (human)
- Drug metabolism - other enzymes - Homo sapiens (human)
- Doxorubicin Pathway, Pharmacokinetics
- Caffeine metabolism - Homo sapiens (human)
Biological Process
- negative regulation of protein phosphorylation
- negative regulation of endothelial cell proliferation
- purine nucleotide catabolic process
- activation of cysteine-type endopeptidase activity involved in apoptotic process
- lactation
Molecular Function
- xanthine dehydrogenase activity
- xanthine oxidase activity
- iron ion binding
- electron transfer activity
- protein homodimerization activity
Cellular Component
- extracellular space
- peroxisome
- cytosol
- sarcoplasmic reticulum
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000379416
- Coding exons
- 36
- Length
- 80395
- Individuals with no LoFs
- 125419
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 328
- Defined
- 125748
- p
- 0.00131
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.45 | 839 | 729 | 1.15 | 0.0000434 | 8729 |
| Missense (PolyPhen) | 317 | 281.44 | 1.1263 | 3371 | ||
| Synonymous | -2.25 | 329 | 281 | 1.17 | 0.0000172 | 2639 |
| Loss of Function | 2.52 | 45 | 67.3 | 0.668 | 0.00000350 | 841 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00062 | 0.00062 | rare |
| Latino/Admixed American | 0.0014 | 0.0014 | notable |
| Ashkenazi Jewish | 0.00079 | 0.00079 | rare |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.0017 | 0.0017 | notable |
| South Asian | 0.0016 | 0.0016 | notable |
| Other | 0.00098 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro). {ECO:0000269|PubMed:17301077}.;
- Disease
- DISEASE: Xanthinuria 1 (XAN1) [MIM:278300]: A disorder characterized by excretion of very large amounts of xanthine in the urine and a tendency to form xanthine stones. Uric acid is strikingly diminished in serum and urine. XAN1 is due to isolated xanthine dehydrogenase deficiency. Patients can metabolize allopurinol. {ECO:0000269|PubMed:10844591, ECO:0000269|PubMed:11379872, ECO:0000269|PubMed:14551354, ECO:0000269|PubMed:9153281}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0937
Intolerance Scores
- LoFtool
- 0.922
- RVIS EVS
- 1.29
- RVIS percentile EVS
- 93.81
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.901
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |